Sunitax Capsule (Sunitinib 25mg/12.5mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | AUREATE |
| Generic Name | Sunitinib |
| Strength | 25mg/12.5mg |
| Pack size | 7 Capsules |
| Used For | Kidney cancer, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
Sutykine Capsule (Sunitinib 50mg/25mg/12.5mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Intas Pharmaceuticals |
| Generic Name | Sunitinib |
| Strength | 50mg-25mg-12-5mg |
| Pack size | 70 Capsules |
| Used For | Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
Sutinat (Sunitinib 50 mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Natco Pharma |
| Generic Name | Sunitinib |
| Strength | 50mg-25mg-12-5mg |
| Pack size | 28 Capsules |
| Used For | Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
Sutib Capsule (Sunitinib 50mg/25mg/12.5mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Glenmark |
| Generic Name | Sunitinib |
| Strength | 50mg-25mg-12-5mg |
| Pack size | 7 Capsules |
| Used For | Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
Sutekast Capsule (Sunitinib 50mg/25mg/12.5mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Aprazer |
| Generic Name | Sunitinib |
| Strength | 50mg-25mg-12-5mg |
| Pack size | 28 Capsules |
| Used For | Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
Nitnib (Sunitinib 50 mg) is an oral anticancer medication used to treat renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Zydus Cadila |
| Generic Name | Sunitinib |
| Strength | 50 mg |
| Pack size | 7 Capsules |
| Used For | Kidney Cancer, Gastrointestinal Stromal Tumors & Pancreatic Neuroendocrine Tumors |
